Serbian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

anticholinergic/запаљење

Веза се чува у привремену меморију
14 резултати

Combination of anticholinergics, .beta.2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The invention relates to novel combinations based on anticholinergics, .beta..sub.2-adrenoceptor agonists, PDE 4 Inhibitors, glucocorticoids, and leukotriene-receptor antagonists, process for their production and their use for the treatment of inflammatory diseases, preferably respiratory diseases

Anti-asthmatic, anti-allergic, anti-cholinergic, bronchodilator and anti-inflammatory 1-[(benzoylphenyl)-lower-alkyl]piperidines and analogs thereof

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND OF THE INVENTION (a) Field of the Invention This invention relates to 1-[(3- or 4-benzoylphenyl)-lower-alkyl]-[(CH.sub.2).sub.n --N.dbd.B]-substituted-piperidines and analogs thereof, useful as anti-asthmatic, anti-allergic, anti-cholinergic, bronchodilator and anti-inflammatory agents;

Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory disease

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The present invention relates to a combination of an inhaled/oral PDE 4 inhibitor in combination with inhaled anticholinergic bronchodilators (muscarinic receptor antagonists), preferentially Roflumilast or AWD-12-281 and R,R-glycopyrrolate, for symptomatic or prophylactic treatment of respiratory

Methods of treating underlying inflammation from COPD or asthma

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The present invention describes the combination of topically inhaled medicinal formulations comprising an anticholinergic component and a glucocorticosteroid component and its use in the symptomatic and prophylactic treatment of diseases of the respiratory tract, especially with an obstructive

Treatment of inflammation using alpha 7 receptor-binding agonists

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND OF THE INVENTION The present invention generally relates to methods of reducing inflammation. More specifically, the invention relates to methods of reducing inflammation using .alpha.7 receptor-binding cholinergic agonists. Vertebrates achieve internal homeostasis during infection or

Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
CROSS REFERENCES TO RELATED APPLICATIONS This application claims priority to European Patent Application No. 13176114.0, filed on Jul. 11, 2013 and European Patent Application No. 13194763.2, filed on Nov. 28, 2013, both of which are incorporated herein by reference in their entireties. BACKGROUND

Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
CROSS REFERENCES TO RELATED APPLICATIONS This application claims priority to European Patent Application No. 15194660.5, filed on Nov. 16, 2015, which is incorporated herein by reference in its entirety. BACKGROUND OF THE INVENTION Field of the Invention The present invention relates to powder

Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
CROSS REFERENCES TO RELATED APPLICATIONS This application claims priority to European Patent Application No. 15194661.3, filed on Nov. 16, 2015, which is incorporated herein by reference in its entirety. BACKGROUND OF THE INVENTION Field of the Invention The present invention relates to powder

Amino-1-[(halophenyl)-lower-alkyl]piperidines

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND OF THE INVENTION (a) Field of the Invention This invention relates to 1-[(3- or 4-benzoylphenyl)-lower-alkyl]-[(CH.sub.2).sub.n -N.dbd.B]-substituted-piperidines and analogs thereof, useful as anti-asthmatic, anti-allergic, anti-cholinergic, bronchodilator and anti-inflammatory agents; to

Benzoylphenyl lower alkanoyl piperidines

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND OF THE INVENTION (a) Field of the Invention This invention relates to 1-[(3- or 4-benzoylphenyl)-lower-alkyl]-[(CH.sub.2).sub.n --N.dbd.B]-substituted-piperidines, useful as anti-asthmatic, anti-allergic, anti-cholinergic, bronchodilator and anti-inflammatory agents, and to certain

Combination of anticholineric and .beta. mimetics for the treatment of respiratory diseases

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The present invention describes a combination of anticholinergic and .beta. mimetics for the treatment of respiratory diseases including airway inflammation or obstruction such as chronic obstructive pulmonary disease (COPD) and asthma. It further comprises the preparation of this combination in a

1-(2'-Aroyl eth-1'yl) 2-(4"-acetamido piperazine-1"yl methyl) benzimidazoles and their therapeutical applications

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The present invention concerns 1-(2'-aroyl eth-1' yl) 2-(4"-acetamido piperazine-1" yl methyl) benzimidazoles, their method of preparation and their application in therapeutics. The compounds of the invention correspond to the following general formula (I): ##STR2## in which: Ar designates: A phenyl

New 1-(2'-aroyl eth-1' yl) 2-(4"-acetamido piperazine-1" yl methyl) benzimidazoles, their therapeutical applications and method for their preparation

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The present invention concerns 1-(2'-aroyl eth-1' yl) 2-(4"-acetamido piperazine-1" yl methyl) benzimidazoles, their method of preparation and their application in therapeutics. THE COMPOUNDS OF THE INVENTION CORRESPOND TO THE FOLLOWING GENERAL FORMULA (I): ##STR2## in which Ar designates A phenyl

Therapeutic application of N-substituted 2-aminomethylene-1,3-indanediones

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to N-substituted 2-aminomethylene-1,3-indanediones and their therapeutic application. 2. Discussion of the Background The present invention relates to products having the structural formula ##STR2## in which R.sub.1
Придружите се нашој
facebook страници

Најкомплетнија база лековитог биља подржана науком

  • Ради на 55 језика
  • Биљни лекови потпомогнути науком
  • Препознавање биљака по слици
  • Интерактивна ГПС мапа - означите биље на локацији (ускоро)
  • Читајте научне публикације повезане са вашом претрагом
  • Претражите лековито биље по њиховим ефектима
  • Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима

Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима

Google Play badgeApp Store badge